Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity
Authors:
- 12 April 2015
- journal article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 16 (2) , 177-182
Abstract
Diffuse large B cell lymphoma (DLBCL) is one of the most common malignancies worldwide. To date, there has been little progress in improving the overall survival of DLBCL patients. Emerging evidences have implicated that long noncoding RNAs (lncRNAs) have important regulatory roles in fundamental biological processes, and some of them are involved in cancer initiation, development and progression. This study was to investigate the expression of lncRNA PEG10 in a cohort of DLBCL patients to assess its clinical value and biological function in DLBCL. We first found that the expression of PEG10 was upregulated in DLBCL tumorous tissues and that cell lines compared with the normal. Moreover, we illustrated that PEG10 was significantly correlated with B symptoms, IPI score, CHOP-like treatment and rituximab. In addition, ROCAUC of PEG10 was up to 0.8228, implicating that PEG10 could be a diagnostic marker for distinguishing DLBCL from normal. Importantly, we verified that PEG10 was a key independent predictive factor for DLBCL prognosis from sizable samples through the longtime follow-ups. Furthermore, we revealed that knockdown of PEG10 expression by siRNA could lead to growth arrest and cell apoptosis in vitro. Our results suggested that PEG10 could represent a novel indicator of poor prognosis and might be served as a potential target for the diagnosis and gene therapy of DLBCL.Keywords
This publication has 19 references indexed in Scilit:
- The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer CellsCancer Research, 2013
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011
- Long noncoding RNAs and human diseaseTrends in Cell Biology, 2011
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisNature, 2010
- PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinomaCancer Genetics and Cytogenetics, 2010
- Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemiaInternational Journal of Cancer, 2007
- Mechanisms of B-cell lymphoma pathogenesisNature Reviews Cancer, 2005
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningNature Medicine, 2002
- A Retrotransposon-Derived Gene, PEG10, Is a Novel Imprinted Gene Located on Human Chromosome 7q21Genomics, 2001